Combined inhibition of tumour necrosis factor-alpha and interleukin-12/23 for long-standing, refractory psoriatic disease: a differential role for cytokine pathways?

De Marco, G, McGonagle, D, Mathieson, HR et al. (5 more authors) (2018) Combined inhibition of tumour necrosis factor-alpha and interleukin-12/23 for long-standing, refractory psoriatic disease: a differential role for cytokine pathways? Rheumatology, 57 (11). pp. 2053-2055. ISSN 1462-0324

Metadata

Authors/Creators:
  • De Marco, G
  • McGonagle, D
  • Mathieson, HR
  • Merashli, M
  • Magee, C
  • FitzGerald, O
  • Goodfield, M
  • Marzo-Ortega, H
Copyright, Publisher and Additional Information: © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. This is an author produced version of a paper published in Rheumatology. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: 1 November 2018
  • Accepted: 4 June 2018
  • Published (online): 4 July 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Experimental Musculoskeletal Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 09 Aug 2018 08:37
Last Modified: 04 Jul 2019 00:39
Status: Published
Publisher: Oxford University Press
Identification Number: https://doi.org/10.1093/rheumatology/key199
Related URLs:

Share / Export

Statistics